List of Excipients in API ISOPROTERENOL HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ISOPROTERENOL HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bausch Health US LLC | ISUPREL | isoproterenol hydrochloride | 0187-4330 | ANHYDROUS CITRIC ACID | |
| Bausch Health US LLC | ISUPREL | isoproterenol hydrochloride | 0187-4330 | EDETATE DISODIUM | |
| Bausch Health US LLC | ISUPREL | isoproterenol hydrochloride | 0187-4330 | HYDROCHLORIC ACID | |
| Bausch Health US LLC | ISUPREL | isoproterenol hydrochloride | 0187-4330 | SODIUM CHLORIDE | |
| Bausch Health US LLC | ISUPREL | isoproterenol hydrochloride | 0187-4330 | SODIUM HYDROXIDE | |
| Bausch Health US LLC | ISUPREL | isoproterenol hydrochloride | 0187-4330 | TRISODIUM CITRATE DIHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ISOPROTERENOL HYDROCHLORIDE
Detailed excipient profiles for ISOPROTERENOL HYDROCHLORIDE
Excipient focus: ANHYDROUS CITRIC ACID
ISOPROTERENOL HYDROCHLORIDE drug variants containing ANHYDROUS CITRIC ACID
ISOPROTERENOL HYDROCHLORIDE drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Nexus Pharmaceuticals Inc | isoproterenol hydrochloride | 14789-011 |
| Cipla USA Inc | isoproterenol hydrochloride | 69097-521 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID ACETATE
ISOPROTERENOL HYDROCHLORIDE drug variants containing CITRIC ACID ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | isoproterenol hydrochloride | 69097-521 |
| >Company | >Ingredient | >NDC |
ISOPROTERENOL HYDROCHLORIDE drug variants not containing CITRIC ACID ACETATE
Excipient focus: CITRIC ACID MONOHYDRATE
ISOPROTERENOL HYDROCHLORIDE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Nexus Pharmaceuticals Inc | isoproterenol hydrochloride | 14789-011 |
| >Company | >Ingredient | >NDC |
ISOPROTERENOL HYDROCHLORIDE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: EDETATE DISODIUM
ISOPROTERENOL HYDROCHLORIDE drug variants containing EDETATE DISODIUM
ISOPROTERENOL HYDROCHLORIDE drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Nexus Pharmaceuticals Inc | isoproterenol hydrochloride | 14789-011 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETIC ACID
ISOPROTERENOL HYDROCHLORIDE drug variants containing EDETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Nexus Pharmaceuticals Inc | isoproterenol hydrochloride | 14789-011 |
| >Company | >Ingredient | >NDC |
ISOPROTERENOL HYDROCHLORIDE drug variants not containing EDETIC ACID
Excipient focus: HYDROCHLORIC ACID
ISOPROTERENOL HYDROCHLORIDE drug variants containing HYDROCHLORIC ACID
ISOPROTERENOL HYDROCHLORIDE drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Nexus Pharmaceuticals Inc | isoproterenol hydrochloride | 14789-011 |
| >Company | >Ingredient | >NDC |
Excipient focus: NITROGEN
ISOPROTERENOL HYDROCHLORIDE drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | isoproterenol hydrochloride | 69097-521 |
| >Company | >Ingredient | >NDC |
ISOPROTERENOL HYDROCHLORIDE drug variants not containing NITROGEN
Excipient focus: SODIUM CHLORIDE
ISOPROTERENOL HYDROCHLORIDE drug variants containing SODIUM CHLORIDE
ISOPROTERENOL HYDROCHLORIDE drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
ISOPROTERENOL HYDROCHLORIDE drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Nexus Pharmaceuticals Inc | isoproterenol hydrochloride | 14789-011 |
| STI Pharma LLC | isoproterenol hydrochloride | 54879-039 |
| Cipla USA Inc | isoproterenol hydrochloride | 69097-521 |
| >Company | >Ingredient | >NDC |
ISOPROTERENOL HYDROCHLORIDE drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
ISOPROTERENOL HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
ISOPROTERENOL HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Nexus Pharmaceuticals Inc | isoproterenol hydrochloride | 14789-011 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
ISOPROTERENOL HYDROCHLORIDE drug variants containing TRISODIUM CITRATE DIHYDRATE
ISOPROTERENOL HYDROCHLORIDE drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Nexus Pharmaceuticals Inc | isoproterenol hydrochloride | 14789-011 |
| STI Pharma LLC | isoproterenol hydrochloride | 54879-039 |
| Cipla USA Inc | isoproterenol hydrochloride | 69097-521 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
ISOPROTERENOL HYDROCHLORIDE drug variants containing WATER
ISOPROTERENOL HYDROCHLORIDE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
